Sibannac Inc.’s Campus Co. Platform Showing Early Signs of Success


Scottsdale, Arizona–(Newsfile Corp. – March 18, 2022) – Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following:

With Eric Stoll coming aboard as the Company’s Chief Marketing Officer, he conceived and has developed The Campus Co. platform. The Campus Co. is a community for start-up and emerging brands in the Solutions Lifestyle category. With a focus on wellness and fitness, the Campus is already bearing fruit.

Currently, we are actively engaged with several companies to develop and bring their innovations to market. We are working with SOMO, innovator of a patent pending sleep mask, integrating the use of the Yin-Tang pressure point into its wearable tech. The sleep market is over $400 billion worldwide.

We are also developing a marketing strategy with Spur Agritech and Spur Biotech, operating in the Controlled Environment Agriculture and Plant-Based Vaccines areas.

The Company is also developing its next generation wellness products through the Campus. Under development is a Copper1 Niacin product through its licensing agreement with the patent owner, Mitosynergy. Mitosynegy has been awarded multiple U.S. patents for molecular compounds for bioavailable coppers, namely Cuprous Nicotinic Acid. We will be bringing a product to market engineered to aid immunity.

Also under development is a product designed around Kratom. Kratom is a plant in the coffee family, native to southeastern Asian countries, and contains a compound called Mitragynine, long used in eastern medicine for natural pain relief. Today, Kratom is growing in popularity as a natural pain relief alternative to prescription drugs. Manufacturing of the product is designated to be done out of our FDA registered facility in Scottsdale.

Sibannac’s CEO, David Mersky, was interviewed on New to The Street, where he discusses the Company’s new products. It will be aired on Newsmax this Sunday, March 20th at 10:00 AM EST and on Fox Business, Tuesday, March 22nd at 10:30 PM PST.

Cautionary Note Regarding Forward-Looking Statements.

This press release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Sibannac, Inc. (the “Company”), its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company’s expectations include, but are not limited to, those factors that are disclosed under the heading “Risk Factors” and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.

Media Contact: [email protected]

To view the source version of this press release, please visit


Please enter your comment!
Please enter your name here